Surgeons raise concerns about Ozempic, other GLP-1s

Surgeons and health system leaders are voicing concerns about the unknown long-term risks of GLP-1 receptor agonists, such as Ozempic, Wegovy and Saxenda.

Related Keywords

United States ,American ,Alfred Trang ,Novo Nordisk Rybelsus ,Tim Schaffner ,Dexter Turnquest ,Joshua Knight ,Bon Secours ,Eli Lilly Byetta ,Christopherc Thompson ,American Society Of Anesthesiologists ,Amylin Pharmaceuticals ,Trinity Health ,Hampton Roads ,Houston Methodist Willowbrook Hospital ,Eli Lilly ,Novo Nordisk ,American Society ,Boston Based Brigham ,Weight Management ,Trinity Health Mid Atlantic ,